Eurordis opened a campaign, called Rare 2030 Action, that is seeking to establish a European action plan for…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
Early, intensive training in motor and memory skills before symptoms develop may delay disease progression and help children with…
A fine balance of proteins called cohesins is important for the normal inactivation of the X chromosome, new research suggests.
Researchers have identified a set of RNA molecules that are dysregulated in Rett syndrome and may be relevant biomarkers…
Novartis Gene Therapies is planning to submit an investigational new drug application (IND) for OAV201, its Rett syndrome gene…
The National Organization for Rare Disorders (NORD)’s RareLaunch training program will host two days of free virtual workshops…
A majority of rare disease patients using telehealth during the COVID-19 pandemic thought the experience positive, and many would like…
A Phase 2 clinical trial evaluating the safety and efficacy of Anavex Life Sciences‘ investigational therapy Anavex…
Stimulation of the vagus nerve, when paired with sound, could help people with Rett syndrome better process what they…
Children with Rett syndrome who can verbalize meaningful words are more likely to be able to walk past age…